Low Testosterone and Hair Loss: The DHT Connection Explained in Full

Male pattern hair loss (androgenetic alopecia) is common in men and is androgen-dependent — but the relevant androgen is dihydrotestosterone (DHT), not testosterone itself [1]. Low testosterone can cause body and facial hair thinning due to reduced androgen stimulation of hair follicles. However, scalp hair loss (MPB) is paradoxically driven by DHT, and men on testosterone replacement therapy may experience worsened scalp hair loss if genetically predisposed.

Does Low Testosterone Cause Hair Loss or Prevent It? Short Answer

The honest answer is both, depending on which hair you mean — and this apparent contradiction is exactly why the topic confuses so many men. For body and facial hair, low testosterone genuinely causes thinning, since these follicles require ongoing androgen stimulation to maintain normal growth, and hypogonadal men commonly notice slower beard growth and reduced chest, abdominal, and leg hair. For scalp hair specifically, the relationship inverts: male pattern baldness is driven predominantly by DHT acting on genetically susceptible scalp follicles, and since low testosterone means less substrate available for conversion to DHT, some hypogonadal men actually experience a slower rate of scalp hair loss than they would at normal testosterone levels. This is precisely why some men notice the reverse pattern after starting TRT — better beard and body hair growth, but accelerated scalp thinning if they carry the genetic susceptibility — and why 'testosterone causes hair loss' is too simple a framing for what's actually a tissue-specific, DHT-mediated, genetically gated process.

DHT vs. Testosterone in Hair Biology

Testosterone converts to DHT via 5-alpha reductase in peripheral tissues including hair follicles. DHT binds androgen receptors in genetically susceptible scalp follicles with 3–5× greater affinity than testosterone, triggering follicle miniaturization and shortening of the hair growth cycle. Scalp follicles express the DHT-sensitive AR variant; body and facial hair follicles are stimulated rather than suppressed by androgens. This explains why hypogonadal men have reduced body hair but may retain scalp hair.

How Low Testosterone Affects Hair

• •Body hair reduction: chest, abdomen, leg, and pubic hair all require androgen stimulation — low T reduces all
• •Facial hair changes: beard growth slows, thins, or becomes patchy with prolonged hypogonadism
• •Scalp hair: paradoxically, low T may slow or stall male pattern baldness progression
• •Hair texture and quality: men with low T often report finer, drier hair across the scalp
• •Eyebrows and eyelashes: can thin with severe hypogonadism

What Regrowth Looks Like When Testosterone Is Corrected

For men whose thinning was driven by genuine testosterone deficiency rather than the DHT-mediated scalp process, correcting the underlying hormonal deficiency (through TRT or by addressing a modifiable cause of low T) can restore body and facial hair growth over a period of months, since these follicles respond directly and positively to restored androgen stimulation. Beard growth becoming fuller and faster, and body hair on the chest and limbs returning toward its prior density, are commonly reported changes within 3 to 6 months of testosterone normalization. This regrowth pattern is a genuinely encouraging and often underappreciated benefit of treating confirmed hypogonadism, distinct from and sometimes in tension with the scalp-hair risk discussed above — a man can reasonably expect improved body and facial hair alongside a need to actively manage scalp hair risk if he's genetically predisposed, rather than assuming testosterone treatment is uniformly good or bad for hair overall.

TRT and Hair Loss Risk

TRT raises testosterone, which increases DHT via 5-alpha reductase. In genetically predisposed men (family history of male pattern baldness, the AR gene variant), TRT can accelerate scalp hair loss. This is one of the more common patient concerns about testosterone therapy. Options: (1) topical finasteride (blocks DHT production in scalp without reducing systemic DHT), (2) minoxidil (promotes hair growth independently of androgens), (3) lower testosterone dose to minimize DHT elevation.

How to Assess Your Own Hair Loss Risk Before Starting TRT

Family history is the single best available predictor of how a man will respond to TRT's effect on scalp hair, since androgenetic alopecia has a strong genetic component tied to androgen receptor sensitivity in scalp follicles. Looking at both sides of the family — maternal and paternal — for pattern baldness gives a reasonable, if imperfect, sense of genetic risk before starting treatment. Men already showing early signs of temple recession or crown thinning before starting TRT are more likely to see that process accelerate once testosterone (and downstream DHT) rises, while men with no family history and no existing thinning by their late 30s or 40s have comparatively lower risk, though not zero. For men who are genetically at-risk but still want or need TRT for confirmed hypogonadism, starting a DHT-blocking strategy (typically topical or low-dose oral finasteride) proactively, rather than waiting for noticeable thinning to appear, is a reasonable preventive approach worth discussing with a prescriber.